Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,1-dichloroethene | increases expression | ISO | Cip2a (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of CIP2A mRNA | CTD | PMID:26682919 | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CIP2A mRNA | CTD | PMID:30723492 | 17beta-estradiol | increases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Estradiol results in increased expression of CIP2A mRNA | CTD | PMID:19167446 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CIP2A mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CIP2A mRNA | CTD | PMID:20106945 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CIP2A mRNA | CTD | PMID:32109520 | 2-palmitoylglycerol | increases expression | ISO | CIP2A (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of CIP2A mRNA | CTD | PMID:37199045 | acrylamide | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of CIP2A mRNA | CTD | PMID:32763439 | benzo[a]pyrene | increases expression | ISO | Cip2a (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CIP2A mRNA | CTD | PMID:32417428 | benzo[a]pyrene | increases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of CIP2A mRNA | CTD | PMID:32234424 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20382639 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CIP2A mRNA | CTD | PMID:25181051 and PMID:34947998 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CIP2A mRNA | CTD | PMID:32145629 | bisphenol A | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of CIP2A mRNA | CTD | PMID:29275510 | butanal | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of CIP2A mRNA | CTD | PMID:26079696 | cadmium dichloride | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of CIP2A protein | CTD | PMID:24527689 | calcitriol | multiple interactions | ISO | CIP2A (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CIP2A mRNA | CTD | PMID:21592394 | calcitriol | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of CIP2A mRNA | CTD | PMID:21592394 | chloroquine | multiple interactions | ISO | CIP2A (Homo sapiens) | 6480464 | Chloroquine inhibits the reaction [temsirolimus results in decreased expression of CIP2A protein] | CTD | PMID:24493623 | cisplatin | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of CIP2A mRNA | CTD | PMID:27392435 | copper(II) sulfate | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CIP2A mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | ISO | CIP2A (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CIP2A mRNA | CTD | PMID:19167446 | dicrotophos | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of CIP2A mRNA | CTD | PMID:28302478 | doxorubicin | increases expression | ISO | Cip2a (Mus musculus) | 6480464 | Doxorubicin results in increased expression of CIP2A mRNA | CTD | PMID:36227756 | enzyme inhibitor | multiple interactions | ISO | CIP2A (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CIP2A protein | CTD | PMID:23301498 | inulin | multiple interactions | ISO | Cip2a (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CIP2A mRNA | CTD | PMID:36331819 | ivermectin | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of CIP2A protein | CTD | PMID:32959892 | lead(0) | affects expression | ISO | CIP2A (Homo sapiens) | 6480464 | Lead affects the expression of CIP2A mRNA | CTD | PMID:28903495 | leupeptin | multiple interactions | ISO | CIP2A (Homo sapiens) | 6480464 | leupeptin inhibits the reaction [temsirolimus results in decreased expression of CIP2A protein] | CTD | PMID:24493623 | lidocaine | increases expression | EXP | | 6480464 | Lidocaine results in increased expression of CIP2A mRNA | CTD | PMID:35283115 | lucanthone | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Lucanthone results in decreased expression of CIP2A mRNA | CTD | PMID:21148553 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of CIP2A gene | CTD | PMID:35440735 | N-Nitrosopyrrolidine | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in decreased expression of CIP2A mRNA | CTD | PMID:32234424 | ozone | decreases expression | ISO | Cip2a (Mus musculus) | 6480464 | Ozone results in decreased expression of CIP2A mRNA | CTD | PMID:24336422 | ozone | multiple interactions | ISO | Cip2a (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CIP2A mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CIP2A mRNA | CTD | PMID:34911549 | paracetamol | increases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CIP2A mRNA | CTD | PMID:22230336 | paracetamol | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of CIP2A mRNA | CTD | PMID:29067470 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cip2a (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CIP2A mRNA | CTD | PMID:36331819 | pravastatin | decreases expression | EXP | | 6480464 | Pravastatin results in decreased expression of CIP2A mRNA | CTD | PMID:27225895 | propanal | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | propionaldehyde results in decreased expression of CIP2A mRNA | CTD | PMID:26079696 | quercetin | increases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Quercetin results in increased expression of CIP2A mRNA | CTD | PMID:21632981 | resveratrol | multiple interactions | ISO | CIP2A (Homo sapiens) | 6480464 | [Coumestrol co-treated with Resveratrol] results in increased expression of CIP2A mRNA and [Plant Extracts co-treated with Resveratrol] results in increased expression of CIP2A mRNA | CTD | PMID:19167446 and PMID:23557933 | silicon dioxide | increases expression | ISO | Cip2a (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of CIP2A mRNA | CTD | PMID:29341224 | sodium arsenite | decreases expression | ISO | Cip2a (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of CIP2A mRNA | CTD | PMID:17998272 and PMID:37682722 | sodium arsenite | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of CIP2A protein | CTD | PMID:30528433 | sunitinib | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of CIP2A mRNA | CTD | PMID:31533062 | Temsirolimus | multiple interactions | ISO | CIP2A (Homo sapiens) | 6480464 | Chloroquine inhibits the reaction [temsirolimus results in decreased expression of CIP2A protein] more ... | CTD | PMID:24493623 | Temsirolimus | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | temsirolimus results in decreased expression of CIP2A mRNA | CTD | PMID:24493623 | testosterone | multiple interactions | ISO | CIP2A (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CIP2A mRNA | CTD | PMID:21592394 | testosterone | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Testosterone results in decreased expression of CIP2A mRNA | CTD | PMID:21592394 and PMID:33359661 | tetrachloromethane | increases expression | ISO | Cip2a (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of CIP2A mRNA | CTD | PMID:29987408 and PMID:31919559 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CIP2A mRNA | CTD | PMID:34492290 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of CIP2A mRNA | CTD | PMID:33387578 | trovafloxacin | decreases expression | ISO | Cip2a (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of CIP2A mRNA | CTD | PMID:35537566 | urethane | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Urethane results in decreased expression of CIP2A mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | CIP2A (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CIP2A mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | CIP2A (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CIP2A mRNA | CTD | PMID:23179753 and PMID:27188386 | vorinostat | increases expression | ISO | CIP2A (Homo sapiens) | 6480464 | vorinostat results in increased expression of CIP2A mRNA | CTD | PMID:27188386 | zaragozic acid A | decreases expression | EXP | | 6480464 | squalestatin 1 results in decreased expression of CIP2A mRNA | CTD | PMID:27225895 | |